Visit us at the 18th WSC in Seoul!
From 21 to 23 October, the 18th World Stroke Congress will take place in Seoul, Korea. EVER Pharma is proud to be part of this important scientific event and to share new clinical data in the field of acute ischemic stroke. We are happy if you visit us at booth #16.
Join the EVER Symposium
📅 22 October 2026
🕛 12:00 – 13:00
📍 Grand Ballroom 103
Bringing Science to the Bedside: Clinically Proven Cerebroprotection in AIS
Chair: Kwang-Yeol Park (Korea)
Co-Chair: Michael Brainin (Austria)
- Can Cerebroprotective Agents Improve BBB Integrity in AIS? New Imaging Study Results
Steven Zeiler (USA) - How Does the CREGS Study Benefit Routine Clinical Practice?
Peter Lackner (Austria)
Don’t miss the opportunity to join the symposium, enjoy a complimentary lunch package and take home our newly released Outcomes II Case Report collection.
We are also pleased to announce that new clinical data on Cerebrolysin® in post-stroke cognitive impairment will be presented by Prof. Michael Brainin during the Late Breaking Science Abstracts 02 Session-ICH, vascular risk & prevention.
📅 21 October 2026
🕙 10:00 – 11:30
📍 Auditorium
Join the session for NEW insights!
We look forward to meeting you in Seoul!